Total Payments
$1,828
2022 Payments
$30.79
Companies
8
Transactions
15
Medicare Patients
587
Medicare Billing
$73,553
Payment Breakdown by Category
Consulting$1,200 (65.6%)
Food & Beverage$628.21 (34.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,200 | 1 | 65.6% |
| Food and Beverage | $628.21 | 14 | 34.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shionogi Inc | $1,324 | 2 | $0 (2019) |
| Allergan Inc. | $172.09 | 7 | $0 (2018) |
| Gilead Sciences, Inc. | $120.51 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $106.59 | 1 | $0 (2018) |
| Accelerate Diagnostics Inc. | $41.20 | 1 | $0 (2019) |
| La Jolla Pharmaceutical Company | $30.79 | 1 | $0 (2022) |
| Dynavax Technologies Corporation | $21.26 | 1 | $0 (2019) |
| ViiV Healthcare Company | $12.11 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $30.79 | 1 | La Jolla Pharmaceutical Company ($30.79) |
| 2019 | $1,519 | 6 | Shionogi Inc ($1,324) |
| 2018 | $154.97 | 2 | Merck Sharp & Dohme Corporation ($106.59) |
| 2017 | $123.71 | 6 | Allergan Inc. ($123.71) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/12/2022 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $30.79 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 07/12/2019 | Accelerate Diagnostics Inc. | ACCELERATE PHENO (Device) | Food and Beverage | Cash or cash equivalent | $41.20 | General |
| Category: Microbiology Lab | ||||||
| 07/03/2019 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Hepatitis B Vaccine | ||||||
| 06/26/2019 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $120.51 | General |
| Category: HIV | ||||||
| 05/15/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: HIV | ||||||
| 03/13/2019 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $123.66 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/12/2019 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/05/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $106.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/21/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $48.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/18/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/17/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/21/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/12/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/06/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/01/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $76.10 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 188 | 252 | $78,772 | $23,364 |
| 2022 | 7 | 181 | 241 | $74,895 | $23,248 |
| 2021 | 7 | 142 | 199 | $63,416 | $19,790 |
| 2020 | 3 | 76 | 85 | $22,450 | $7,151 |
Total Patients
587
Total Services
777
Medicare Billing
$73,553
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 70 | $19,423 | $5,840 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 46 | $17,870 | $5,788 | 32.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 57 | $17,619 | $5,156 | 29.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $11,412 | $3,280 | 28.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $8,501 | $1,978 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 18 | $3,528 | $1,139 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 22 | $419.00 | $184.80 | 44.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 49 | $19,012 | $6,406 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 67 | $18,626 | $6,141 | 33.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 52 | $15,704 | $4,074 | 25.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $9,571 | $2,572 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $7,125 | $2,382 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 24 | $4,704 | $1,622 | 34.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 17 | $153.00 | $50.22 | 32.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 62 | $18,927 | $4,977 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 48 | $12,919 | $4,617 | 35.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 30 | $11,280 | $3,922 | 34.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $7,287 | $2,433 | 33.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $6,661 | $1,867 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 17 | $3,142 | $1,135 | 36.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 15 | $3,200 | $837.90 | 26.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 49 | $12,779 | $4,175 | 32.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $5,941 | $1,807 | 30.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 21 | $3,730 | $1,169 | 31.3% |
About Dr. Mary Bowman, MD
Dr. Mary Bowman, MD is a Infectious Disease healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629039243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Bowman, MD has received a total of $1,828 in payments from pharmaceutical and medical device companies, with $30.79 received in 2022. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($1,200).
As a Medicare-enrolled provider, Bowman has provided services to 587 Medicare beneficiaries, totaling 777 services with total Medicare billing of $73,553. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Chapel Hill, NC
- Active Since 03/31/2006
- Last Updated 10/31/2025
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1629039243
Products in Payments
- Fetroja (Drug) $1,324
- Biktarvy (Drug) $120.51
- DIFICID (Drug) $106.59
- DALVANCE (Drug) $104.59
- AVYCAZ (Drug) $60.56
- ACCELERATE PHENO (Device) $41.20
- XERAVA (Drug) $30.79
- Heplisav-B (Drug) $21.26
- DOVATO (Drug) $12.11
- TEFLARO (Drug) $6.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Chapel Hill
David Wohl, M.d, M.D
Infectious Disease — Payments: $941,907
Infectious Disease $941,907
Dr. Joseph Eron, Md, MD
Infectious Disease — Payments: $227,043
Infectious Disease $227,043
Dr. David Van Duin, M.d, M.D
Infectious Disease — Payments: $85,138
Infectious Disease $85,138
Dr. Myron Cohen, Md, MD
Infectious Disease — Payments: $59,254
Infectious Disease $59,254
Dr. David Margolis, Md, MD
Infectious Disease — Payments: $44,821
Infectious Disease $44,821
Dr. Michelle Floris-Moore, Md, MD
Infectious Disease — Payments: $26,360
Infectious Disease $26,360